iiinova — where your digital self keeps evolving

Reposted by Deji Adegunsoye, MD, PhD

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 09/05/2026

ILD patients desaturate on exertion but recover quickly in early disease BUT as things worsen SpO2 recovery takes longer 🫁 "Recovery Rate from Exertional Desaturation Is Ass'd with Disease Progression and Mortality Risk in fibrotic ILD" Free article d/load👇 authors.elsevier.com/a/1n3wf2p-lH...

Figure 2. Greater RI correlates with lower baseline %FVC and %Dlco in the Calgary (A, B) and Chicago (C, D) cohorts. Dlco = diffusing capacity of the lung for carbon monoxide; RI = recovery index.

1102

Reposted by Deji Adegunsoye, MD, PhD

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 09/05/2026

Recovery Index (RI) is associated w/ baseline lung function, progression and mortality Kudos Dr. Albina Tyker for leading this work 🌟 Collaboration between @ucalgarymed.bsky.social & @uchicagomedicine.bsky.social ILD programs @drdayjee.bsky.social @agrantorser.bsky.social @accpchest.bsky.social ⭐

031

Reposted by Deji Adegunsoye, MD, PhD

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 17/04/2026

Dr. Veronica Marcoux presents official Canadian Thoracic Society position statement “Infection screening before starting immunosuppression in interstitial lung disease” 🫁 Addressing MTB, HIV, HBV, HCV & strongyloides @veronicasam940.bsky.social 👏 #OpenAccess www.tandfonline.com/doi/full/10....

Dr Marcoux at podium with slide in background

Summary of recommendations from the paper

295

Reposted by Deji Adegunsoye, MD, PhD

KaminskiMed @kaminskimed.bsky.social · 01/12/2025

Finally in Print! The Official ATS Research Statement on Racial, Ethnic, Sex & Gender Equity for Inclusive Interstitial Lung Disease Research. 👏🏼 Drs Assayag, Adegonsoye, Cottin, Mageto & @atsblueeditor.bsky.social & @atscommunity.bsky.social #CurePF4All www.atsjournals.org/doi/10.1164/...

084

Reposted by Deji Adegunsoye, MD, PhD

ATS Clinical Problems Assembly @ats-clinicalprobs.bsky.social · 18/05/2025

From cutting-edge diagnostics to evolving management strategies—don't miss "Advances in the Diagnosis and Management of #ILD" with Drs. @drdayjee.bsky.social, Joyce Lee, & Michael Kreuter #ATS2025 📆 5/18/25 9:15-11:15am 📍 Room 25, Hall E (North Building, Exhibition Level), Moscone Center

011

Reposted by Deji Adegunsoye, MD, PhD

Dr. Dawn Bowdish @msmacrophage.bsky.social · 15/04/2025

Thank you @drdayjee.bsky.social for an exceptional talk on ethnic and racial disparities on pulmonary fibrosis @ #TheFirestone. So important to understand how time of diagnosis, progression, and pathology differ for both clinicians and researchers. #lungsky #pulmsky #CurePF #lungs

1111

Reposted by Deji Adegunsoye, MD, PhD

KaminskiMed @kaminskimed.bsky.social · 26/12/2024

To all interested in all things related to Pulmonary Fibrosis - the #CureFibrosis starter pack is ready for 2025 - please let me know if you wish to be included and ofcourse follow - use #CurePF4All #CureIPF #CureFibrosis etc #HappyNewYear go.bsky.app/6hgNDdr

163114